Bio­Marin looks for fast ap­proval of he­mo­phil­ia A gene ther­a­py; In­ves­ti­ga­tors tout En­ta­sis an­tibi­ot­ic

Bio­Marin $BM­RN told an­a­lysts dur­ing its R&D day that new FDA rules may make it pos­si­ble to file for an FDA ap­proval on …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.